MMP14 and triple-negative breast carcinoma: Application of an MT1-MMP antibody to a 4T1 triple-negative breast cancer mouse model shifted macrophages towards the antitumor M1-like phenotype and reduced activated TGFβ (an immunosuppressive cytokine) [166].